ICAM1 and angina pectoris: Regarding ACS, a study that included 75 patients measured circulating levels of ICAM-1 and VCAM-1, VCAM-1 showed to be a powerful predictor of major events in this patient profile; however, a new coronary event, hospitalization for angina, or cardiac death were considered adverse outcomes.